Dr
Droit
Machine-executable regulatory logic for trade eligibility and reporting
Droit encodes cross-jurisdiction regulations as executable rules that determine in real time whether trades or products are permissible and drive derivatives reporting with audit trails. Its clients were primarily large dealers, and since its March 2026 acquisition it is being absorbed into FIS's capital markets compliance suite.
GAII take
Deterministic rules approach suits auditability; buy-side users should confirm product continuity and roadmap inside FIS.
Deterministic rules approach suits auditability; buy-side users should confirm product continuity and roadmap inside FIS.
- Website
- droit.tech
- Headquarters
- New York, NY, USA
- Founded
- 2012
- Company type
- Incumbent
- Funding
- $39M · Series B
- Latest round
- Acquired by FIS, terms undisclosed, March 2026; last venture round was Series B, $23m, March 2023 (Pivot Investment Partners)
- Status
- Active — Acquired by FIS in March 2026 for undisclosed terms and being folded into the FIS capital markets compliance business; as at this review the droit.tech product
- Buyer
- Investment banks
- Asset class
- Multi-assetFixed income & credit
- Workflow
- ComplianceTrading & execution
- Ai capability
- Knowledge graphAgents & automation
- Delivery
- SaaS applicationAPI / data feed
GAII ID GAII-T0144 · Updated 2026-10-22 · Compiled from public sources for educational and informational purposes. Not investment advice.